Becton Dickinson and Co vs Cardinal Health Inc — how do they compare? Becton Dickinson and Co trades at $181.29 (market cap $49.41B), while Cardinal Health Inc trades at $240.52 (market cap $55.88B). The key difference: Becton Dickinson and Co and Cardinal Health Inc are close in size by market cap, and Becton Dickinson and Co pays the higher dividend (2.32%). Which is the better fit depends on your goals.
| BDX | CAH | |
|---|---|---|
Market Cap | $49.41B | $55.88B |
Sector | Health | Health |
52-Week High | $185.39 | $240.26 |
52-Week Low | $138.62 | $146.04 |
Enterprise Value | $65.51B | $59.91B |
Dividend Yield | 2.32% | 0.86% |
Trailing returns across standard periods
Latest headlines on both assets
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →